Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
2013
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
2014 Standout
Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy
2006
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
ROS stress in cancer cells and therapeutic implications
2004 Standout
Myeloid Growth Factors
2011
Gender medicine and oncology: report and consensus of an ESMO workshop
2019
Fertility and adjuvant treatment in young women with breast cancer
2007
Nucleotide signalling during inflammation
2014 StandoutNature
Extracellular adenosine triphosphate and adenosine in cancer
2010
Global patterns and trends in the incidence of non-Hodgkin lymphoma
2019
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells
2003
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
NOX enzymes and the biology of reactive oxygen
2004 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Gonadal function and parenthood 20 years after treatment for childhood lymphoma: A cross‐sectional study
2011
Hormonal suppression for fertility preservation in males and females
2008
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Combination of the anti‐CD30‐auristatin‐E antibody‐drug conjugate (SGN‐35) with chemotherapy improves antitumour activity in Hodgkin lymphoma
2008
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Free Radicals: Properties, Sources, Targets, and Their Implication in Various Diseases
2014 Standout
Comparison of pegfilgrastim with filgrastim on febrile neutropenia, grade IV neutropenia and bone pain: a meta-analysis of randomized controlled trials
2007
Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways
2008 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
2009
Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells
2006
Late Effects of Hodgkin’s Disease and Its Treatment
2009
Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications
2013
ROS signalling in the biology of cancer
2017 Standout
Preservation of Fertility in Patients with Cancer
2009 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Hydrogen Peroxide: A Signaling Messenger
2006 Standout
Hodgkin lymphoma: 2018 update on diagnosis, risk‐stratification, and management
2018
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
2014 Standout
Revised Response Criteria for Malignant Lymphoma
2007 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
2015
Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
2006
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Beate Klimm being referenced
Differences in hematotoxicity between male and female patients with Hodgkin lymphoma and other malignancies
2008
An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma
2013
Current treatment strategies of the German Hodgkin Study Group (GHSG)
2005
Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group
2005
Lymphocyte-Depleted Classical Hodgkin's Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group
2011
Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial
2012
Role of Hematotoxicity and Sex in Patients With Hodgkin's Lymphoma: An Analysis From the German Hodgkin Study Group
2005
Pegfilgrastim Supports Delivery of BEACOPP Chemotherapy Administered Every 14 Days.
2004
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group
2011
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group
2014
Current treatment and immunotherapy of Hodgkin's lymphoma.
2005
Activation of p90RSK and growth stimulation of multicellular tumor spheroids are dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP
2001